Provided by Tiger Fintech (Singapore) Pte. Ltd.

Guardant Health Inc.

50.23
+0.19990.40%
Volume:184.52K
Turnover:9.27M
Market Cap:6.22B
PE:-14.87
High:50.93
Open:50.30
Low:49.57
Close:50.03
Loading ...

GH Research PLC (GHRS): Among the Best Psychedelic Stocks to Buy in 2025

Insider Monkey
·
02 Mar

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
01 Mar

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire
·
01 Mar

Promising Trial Results and Strong Financials Justify Buy Rating for GH Research

TIPRANKS
·
28 Feb

Analysts Are Bullish on Top Healthcare Stocks: GH Research (GHRS), Cullinan Management (CGEM)

TIPRANKS
·
28 Feb

Psychedelic: GH Research, Compass Pathways report earnings results

TIPRANKS
·
28 Feb

GH Research Is Maintained at Buy by Stifel

Dow Jones
·
27 Feb

New Guardant Health/Harris Poll Survey Highlights Patient Fear and Anxiety as Major Barriers to Colorectal Cancer Screening, but Blood Test Option Offers Hope for Change

Business Wire
·
27 Feb

GH Research 2024 GAAP EPS $(0.75), Down From $(0.68) YoY

Benzinga
·
27 Feb

GH Research Reports Full Year 2024 Financial Results and Provides Business Updates

GlobeNewswire
·
27 Feb

Guardant Health Is Maintained at Overweight by Piper Sandler

Dow Jones
·
27 Feb

Guardant Health (GH): Among the Best Performing Mid Cap Stocks to Buy According to Analysts

Insider Monkey
·
27 Feb

Stock Track | Guardant Health Soars 5.08% as Piper Sandler Raises Price Target

Stock Track
·
26 Feb

Guardant Health price target raised to $50 from $34 at Piper Sandler

TIPRANKS
·
26 Feb

Is Guardant Health (GH) Outperforming Other Medical Stocks This Year?

Zacks
·
25 Feb

GH Research PLC (GHRS): Among the Best Performing Small Cap Stocks So Far In 2025

Insider Monkey
·
25 Feb

2 Stocks Down 59% and 34% to Buy and Hold

Motley Fool
·
25 Feb

Guardant Health Is Maintained at Sector Outperform by Scotiabank

Dow Jones
·
24 Feb

Guardant Health Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
24 Feb

Guardant Health Inc : Scotiabank Raises Target Price to $52 From $47

THOMSON REUTERS
·
24 Feb